沽空銷售量（含暗池和交易所數據）
LGND / Ligand Pharmaceuticals Incorporated的沽空交易量如以下圖表所示。沽空交易量顯示了各個交易場所中被標記為沽空交易的交易數量。欲了解更多有關如何解讀此數據的信息，請閱讀FINRA提供的此 資訊通知。
- FINRA 沽空交易量
- FINRA報告的場外空頭交易股票數量， 包括豁免和非豁免。
- CBOE 沽空交易量
- CBOE報告的空頭交易股票數量。
- PSX/BX 沽空交易量
- NASDAQ報告的在PSX/BX交易場所空頭交易股票數量。
- 整體沽空交易量
- FINRA沽空交易量 + CBOE沽空交易量 + PSX/BX沽空交易量。
- 整體總交易量
- FINRA總交易量 + CBOE總交易量 + PSX/BX總交易量。
- 整體沽空交易量比率
- 整體沽空交易量 / 整體總交易量
更新頻率：每日收盤後
| 市場日期 | FINRA 沽空交易量 |
PSX/BX 沽空交易量 |
整體 沽空交易量 |
整體 總交易量 |
整體 沽空比率 |
||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 65,376 | + | 405 | = | 65,781 | / | 79,359 | = | 82.89 |
| 2026-06-04 | 82,901 | + | 1,200 | = | 84,101 | / | 118,536 | = | 70.95 |
| 2026-06-03 | 31,396 | + | 2,420 | = | 33,816 | / | 42,676 | = | 79.24 |
| 2026-06-02 | 54,386 | + | 1,000 | = | 55,386 | / | 63,276 | = | 87.53 |
| 2026-06-01 | 66,151 | + | 0 | = | 66,151 | / | 76,914 | = | 86.01 |
| 2026-05-29 | 45,136 | + | 600 | = | 45,736 | / | 55,588 | = | 82.28 |
| 2026-05-28 | 31,984 | + | 925 | = | 32,909 | / | 43,865 | = | 75.02 |
| 2026-05-27 | 67,892 | + | 0 | = | 67,892 | / | 97,166 | = | 69.87 |
| 2026-05-26 | 86,792 | + | 986 | = | 87,778 | / | 103,382 | = | 84.91 |
| 2026-05-22 | 129,765 | + | 100 | = | 129,865 | / | 170,363 | = | 76.23 |
| 2026-05-21 | 33,945 | + | = | / | = | ||||
| 2026-05-20 | 66,229 | + | 663 | = | 66,892 | / | 79,970 | = | 83.65 |
| 2026-05-19 | 54,613 | + | 2,876 | = | 57,489 | / | 82,004 | = | 70.11 |
| 2026-05-18 | 40,330 | + | 600 | = | 40,930 | / | 60,273 | = | 67.91 |
| 2026-05-15 | 37,243 | + | 200 | = | 37,443 | / | 49,074 | = | 76.30 |
| 2026-05-14 | 46,193 | + | 550 | = | 46,743 | / | 58,531 | = | 79.86 |
| 2026-05-13 | 73,571 | + | 500 | = | 74,071 | / | 87,634 | = | 84.52 |
| 2026-05-12 | 52,197 | + | 900 | = | 53,097 | / | 64,985 | = | 81.71 |
| 2026-05-11 | 60,390 | + | 200 | = | 60,590 | / | 78,625 | = | 77.06 |
| 2026-05-08 | 72,429 | + | 251 | = | 72,680 | / | 110,316 | = | 65.88 |
| 2026-05-07 | 218,381 | + | 800 | = | 219,181 | / | 345,921 | = | 63.36 |
